| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/28/1999 | EP0931090A1 Improved chimeric oligonucleotide vectors |
| 07/28/1999 | EP0931088A1 Novel erythromycin derivatives, method for preparing same and use thereof as drugs |
| 07/28/1999 | EP0931087A1 Novel pyranoside derivatives |
| 07/28/1999 | EP0931086A1 Tetrahydronaphthalene derivatives and their therapeutic use |
| 07/28/1999 | EP0931084A1 1,3-dicarboxylic germanium complex and its therapeutic use |
| 07/28/1999 | EP0931083A1 Process for producing ecteinascidin compounds |
| 07/28/1999 | EP0931082A1 Nodulisporic acid derivatives |
| 07/28/1999 | EP0931081A1 Pyridazino 4,5-b]-quinoline 5-oxide derivatives, their preparation and their use as glycine antagonists |
| 07/28/1999 | EP0931080A1 Amorphous paroxetine composition |
| 07/28/1999 | EP0931079A1 Substituted benzocycloheptapyridine derivatives useful for inhibition of farnesyl protein transferase |
| 07/28/1999 | EP0931078A1 Novel tricyclic piperidinyl compounds useful as inhibitors of farnesyl-protein transferase |
| 07/28/1999 | EP0931077A1 Substituted benzocycloheptapyridine useful as inhibitors of farnesyl-protein transferase |
| 07/28/1999 | EP0931075A1 Indazole derivatives and their use as inhibitors of phosphodiesterase (pde) type iv and the production of tumor necrosis factor (tnf) |
| 07/28/1999 | EP0931071A1 Methods of making hiv-protease inhibitors and intermediates for making them |
| 07/28/1999 | EP0931067A1 D4 receptor selectivity piperazine derivatives |
| 07/28/1999 | EP0931065A2 Nitric ester derivatives and their use in urinary incontinence and other diseases |
| 07/28/1999 | EP0931063A1 N-substituted indol-3-glyoxylamid with antiasthmatic, antiallergic and immunosuppressive/immunomodulating effect |
| 07/28/1999 | EP0931060A1 Substituted n- (aminoiminomethyl or aminomethyl)phenyl]propyl amides |
| 07/28/1999 | EP0931056A1 N-substituted-2-amino-4-phenyl-4-oxo-butanoic acid derivatives with kynurenine-3-hydroxylase inhibitory activity |
| 07/28/1999 | EP0931045A1 Matrix metalloproteinase inhibitors and their therapeutic uses |
| 07/28/1999 | EP0930895A1 Preparation of protein/polysaccharide conjugate vaccines using homobifunctional and heterobifunctional vinylsulfones |
| 07/28/1999 | EP0930893A1 Immunostimulatory polynucleotide/immunomodulatory molecule conjugates |
| 07/28/1999 | EP0930889A1 CITRUS PEEL EXTRACT AS 3-HYDROXY-3-METHYLGLUTARYL CoA(HMG-CoA) REDUCTASE INHIBITOR |
| 07/28/1999 | EP0930888A1 Pharmaceutical and cosmetic antiacne formulations containing plant extracts (krameria triandra or mesua ferrea) |
| 07/28/1999 | EP0930886A1 Formulation for use in the prevention of pathogen induced diseases including hiv and hsv |
| 07/28/1999 | EP0930885A1 The use of heparin or heparan sulphate in combination with chitosan for the prevention or treatment of infections caused by herpes virus |
| 07/28/1999 | EP0930884A1 Soporific containing lorazepam and diphenhydramine |
| 07/28/1999 | EP0930883A1 Neurotrophin antagonist compositions |
| 07/28/1999 | EP0930882A2 Prevention or treatment of type 2 diabetes or cardiovascular disease with ppar modulators |
| 07/28/1999 | EP0930881A1 Pyrazolinones to treat disturbances of potency |
| 07/28/1999 | EP0930880A1 Pharmaceutical composition comprising a combination of isosorbide nitrate with acetylsalicylic acid |
| 07/28/1999 | EP0930879A2 Use of calcium dobesilate for the manufacture of a medicament for the treatment of embryonic retardation |
| 07/28/1999 | EP0930878A1 Use of sodium 2-mercaptoethanesulfonate in surgery |
| 07/28/1999 | EP0930877A1 Therapeutic use of d-methionine to reduce the toxicity of platinum-containing anti-tumor compounds |
| 07/28/1999 | EP0930876A2 Use of sex steroid function modulators to treat wounds and fibrotic disorders |
| 07/28/1999 | EP0930874A2 A method for producing a microparticle |
| 07/28/1999 | EP0930870A1 Preparation protecting skin from mechanical irritation |
| 07/28/1999 | EP0930831A1 Flavonol containing food supplements |
| 07/28/1999 | EP0930821A1 Antimicrobial lipids |
| 07/28/1999 | EP0874639A4 Peptide inhibitors of a phosphotyrosine-binding domain containing protein |
| 07/28/1999 | EP0766665B1 Metalloproteinase inhibitors |
| 07/28/1999 | EP0737189B1 Heterocyclic compounds for the treatment of cns and cardiovascular disorders |
| 07/28/1999 | EP0705265B1 Novel chemical compounds having pde-iv inhibition activity |
| 07/28/1999 | EP0643693B1 Reversal of multi-drug resistance by triphenyl-piperidine derivatives |
| 07/28/1999 | EP0604494B1 5-ht4 receptor antagonists |
| 07/28/1999 | EP0531419B1 Bistriazenes as chemotherapeutic agents |
| 07/28/1999 | CN1224429A Androstene derivs. |
| 07/28/1999 | CN1224428A Cellular injury response element and uses thereof |
| 07/28/1999 | CN1224427A 6-0-substd. erythromycins and method for making them |
| 07/28/1999 | CN1224426A 3-descladinose-2,3-anhydroerythromycin derivs. |
| 07/28/1999 | CN1224425A Phophorus contg. cythesine derivs. |
| 07/28/1999 | CN1224424A Azolobenzazepine derivs. as neurologically active agents |
| 07/28/1999 | CN1224416A Creatine pyruvates and method for their production |
| 07/28/1999 | CN1224355A Injections contg. lipid A analogues and process for preparation thereof |
| 07/28/1999 | CN1224354A Drugs for ameliorating pulmonary circulation |
| 07/28/1999 | CN1224353A Virginiamycin mixture |
| 07/28/1999 | CN1224352A Anticonvulsant sulfamate derivs. useful in treating obesity |
| 07/28/1999 | CN1224351A Pharmaceutical preparation contg. nimesulide for oral administration |
| 07/28/1999 | CN1224350A Use of topiramate or derivs. thereof for manufacture of medicament for treatment of manic-depressive bipolar disorders |
| 07/28/1999 | CN1224347A High dose liposomal aerosol formulations |
| 07/28/1999 | CN1224023A Medicinal use of total sterone in Radix Rhapontici and preparing method thereof |
| 07/28/1999 | CN1224018A Phosphonic carboxylate compounds, pharmaceutical compositions contg. same |
| 07/28/1999 | CN1224016A Antineoplastic and insecticidal total annonacin and preparing process thereof |
| 07/28/1999 | CN1224015A Diindole heterocyclic compounds, preparing method and use thereof |
| 07/28/1999 | CN1224011A New heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them |
| 07/28/1999 | CN1224005A Anticancer thiosemicarbazides compounds and their producing process |
| 07/28/1999 | CN1223862A External use medicine for treating open wound |
| 07/28/1999 | CN1223859A Process for preparation of pharmaceutical composition |
| 07/28/1999 | CN1223853A Cosmetic and pharmaceutical preparations comprising ascorbic acid derivatives |
| 07/28/1999 | CN1044367C (S)-alpha-phenyl-2-pyridine-ethylamine, its preparing method and composition contg. same |
| 07/28/1999 | CN1044366C Aryl-pyrrolidine-dione derivs., their preparing process and insecticidal and herbicidal agents contg. them and insecticidal and herbicidal use thereof |
| 07/28/1999 | CN1044365C Alpha, omega-diarylalkane derivs., their preparation and their use in treatment and prevention of circulatory diseases and psychosis |
| 07/28/1999 | CN1044364C Medicine for treating enteritis and ulcer colitis and prepn. method thereof |
| 07/28/1999 | CN1044321C Medicinal composition for treating women's climacteric syndrome |
| 07/28/1999 | CN1044320C Semduramicin premix preparing process |
| 07/28/1999 | CN1044319C Hot melt antihistamine formulations preparing process |
| 07/27/1999 | US5929249 Angiotensin ii receptor antagonists |
| 07/27/1999 | US5929248 Antibacterial agents |
| 07/27/1999 | US5929247 Heterocyclic compounds and their preparation and use |
| 07/27/1999 | US5929237 Conformationally constrained compounds which mimic the secondary structure of reverse-turn regions of biologically active peptides and proteins; for random drug screening |
| 07/27/1999 | US5929236 2-substituted morpholine and thiomorpholine derivatives as GABA-B antagonists |
| 07/27/1999 | US5929226 Three or more but not all nucleotides are connected with methylphosphonothioate linkages where sulfur is not bridging atom; increased resistance to nucleases, increased duplex stability |
| 07/27/1999 | US5929220 Hepadnavirus receptor |
| 07/27/1999 | US5929213 Antibodies to growth differentiation factor-12 |
| 07/27/1999 | US5929184 Anticholesterol |
| 07/27/1999 | US5929123 Antioxidant compounds |
| 07/27/1999 | US5929122 Combination preparation containing tramadol and a calcium channel antagonist |
| 07/27/1999 | US5929120 Guainidino, formamidino, amino and related compounds for inhibiting osteoclast-mediated bone resorption |
| 07/27/1999 | US5929117 Immunotherapeutic agents |
| 07/27/1999 | US5929115 Aqueous mixture containing diclofenac sodium, cyclodextrin, polyvinyl pyrrolidone and one of benzethonium chloride or benzalkonium chloride; storage stability |
| 07/27/1999 | US5929114 Administering antiviral compound which extrudes zinc from nucleocapsid protein of human immunodeficiency virus |
| 07/27/1999 | US5929113 Compositions comprising EMU oil or active fractions thereof and methods of using these compositions as insect repellents |
| 07/27/1999 | US5929112 Use in pharmaceuticals or cosmetics as antioxidants, improved bioavailability |
| 07/27/1999 | US5929111 A-seco steroids effective at treating ophthalmic pathological neovascularization and controlling intraocular pressure |
| 07/27/1999 | US5929109 Enhancing and stabilizing agent of the activity of Bifidus factor |
| 07/27/1999 | US5929105 Ethylene glycol esters as photoactive agents |
| 07/27/1999 | US5929104 Method for inducing apoptosis of cancer cell |
| 07/27/1999 | US5929103 Anticarcinogenic agents |
| 07/27/1999 | US5929101 Administering thiazolidinedione derivatives |
| 07/27/1999 | US5929100 Biologically active benzothiazolone ethanamines |